478 filings
10-Q
2024 Q1
RGEN
Repligen Corp.
Quarterly report
1 May 24
4:22pm
8-K
RGEN
Repligen Corp.
1 May 24
Repligen Reports First Quarter 2024 Financial Results
7:44am
ARS
2023 FY
RGEN
Repligen Corp.
1 Apr 24
Annual report to shareholders
4:32pm
DEFA14A
RGEN
Repligen Corp.
1 Apr 24
Additional proxy soliciting materials
4:21pm
DEF 14A
RGEN
Repligen Corp.
Definitive proxy
1 Apr 24
4:17pm
8-K
sbpaz5n90 bi
19 Mar 24
Repligen Appoints Maggie A. Pax to Board of Directors
7:41am
8-K
zxypq
21 Feb 24
Repligen Reports Fourth Quarter and Full Year 2023 Financial Results
7:47am
8-K
5k6k964qq0q50lgi1
15 Dec 23
Entry into a Material Definitive Agreement
4:33pm
8-K
2ao7r0rf e94mo
7 Dec 23
Unregistered Sales of Equity Securities
7:39am
8-K
4wjrb9
31 Oct 23
Repligen Reports Third Quarter 2023 Financial Results
7:48am
8-K
nosdss9xexu
2 Oct 23
Repligen Appoints Olivier Loeillot As President and Chief Commercial Officer
7:42am
8-K
ewluach
26 Sep 23
Repligen Announces Agreement to Acquire
7:44am
8-K
0br2aai
12 Sep 23
Repligen Appoints Jason K. Garland As Chief Financial Officer
9:20am
8-K
hdrub8uk f3ya1cw260
2 Aug 23
Repligen Reports Second Quarter 2023 Financial Results
7:54am
8-K
1mj hr304645jqp0g9x
22 May 23
Amendments to Articles of Incorporation or Bylaws
9:28am
8-K
b9lnl
2 May 23
Repligen Reports First Quarter 2023 Financial Results
7:48am